Trump Administration Cuts Funding for Trans Surgeries on Minors
The Trump administration will stop federal health programs from funding gender transition procedures for minors, directing Medicare chief Dr. Oz to implement the policy change.
President Donald Trump has directed that Medicaid and the Children’s Health Insurance Program (CHIP) will cease covering gender reassignment surgeries, puberty blockers, and hormone treatments for individuals under 18 or 19 years of age, depending on the program, according to Nius. The decision affects all such medical procedures classified as gender-affirming care for minors enrolled in these taxpayer-funded health schemes.
Trump has tasked Dr. Mehmet Oz, the newly appointed head of Medicare and Medicaid services, with implementing the policy change. The president made clear his position on the matter, stating that the government would not subsidize what he termed barbaric procedures performed on innocent children. Funding for psychological counseling services for young people experiencing gender dysphoria will continue under the new framework.
Broader Push Against Medical Transitioning of Minors
The funding cutoff represents part of a wider administration effort to curtail gender transition treatments for children across the United States. Federal authorities have also threatened to withhold funding from hospitals and medical facilities that continue to perform such procedures on underage patients, creating substantial financial pressure on healthcare institutions to comply with the new policy direction.
Republican lawmakers and conservative advocacy organizations have welcomed the announcement as a necessary safeguard protecting children from irreversible medical interventions that they argue are being performed without adequate consideration of long-term consequences. These supporters contend that minors lack the capacity to provide informed consent for procedures that permanently alter their bodies and reproductive capabilities.
Opposition Groups Promise Legal Challenge
LGBT advocacy organizations have condemned the policy in harsh terms. The Human Rights Campaign and similar groups characterize the decision as a politically motivated attack on transgender youth and have announced their intention to pursue legal action to block implementation of the funding restrictions.
The administration’s move places the United States in alignment with several European nations that have recently scaled back medical transition procedures for minors following reviews of the evidence base supporting such interventions. The policy shift is expected to face immediate court challenges as it rolls out across federal health programs.
With information from Nius
